Madurna's Cove 19 Vaccine Shows Modest Effectiveness

Madurna says its cove 19 vaccine produced a strong immune response in children under age six and initial s from a large final stage trial, but it showed only modest effectiveness. Drew armstrong, drew, what are we supposed to make of this efficacy data? And why has it been so hard to get this vaccine buttoned up for kids five and under.